Nerdipina Retard (Nicardipine Hydrochloride)

Nicardipine hydrochloride, the active ingredient in Nerdipina Retard, is a calcium channel blocker presented as an oral formulation for oral use. It is used to treat hypertension and chronic stable angina in adult patients. GNH USA supplies Nerdipina Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nerdipina Retard belongs to the calcium channel blocker class and is indicated for cardiovascular conditions that benefit from arterial vasodilation. - Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. - Chronic stable angina: improves exercise tolerance by decreasing myocardial oxygen demand. - Coronary artery disease (angina pectoris): alleviates chest pain episodes through enhanced coronary blood flow.

Adverse reactions may occur with any dosage form of nicardipine.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warm sensation, usually resolves without intervention. - Peripheral edema: swelling of ankles or lower legs. - Dizziness or light‑headedness, especially when standing quickly. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare but possible in susceptible patients. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Severe bradycardia: markedly slow heart rate. - Allergic reactions: rash, pruritus, or anaphylaxis. - Neutropenia: significant reduction in white blood cells.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Monitor blood pressure: adjust dose to maintain target range. - Assess cardiac function: especially in patients with existing heart disease. - Review concomitant antihypertensives: avoid excessive hypotension. - Use caution in hepatic impairment: dose may need adjustment. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicardipine may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase nicardipine plasma concentrations. - Other calcium channel blockers: additive hypotensive effect. - Grapefruit juice: can raise systemic exposure.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce therapeutic effect. - Diuretics: enhanced blood‑pressure lowering, monitor electrolytes. - Beta‑blockers: may require dose adjustment to avoid excessive heart‑rate reduction.